Angiotropic B-cell lymphoma (malignant angioendotheliomatosis): failure of systemic chemotherapy

R E Williams; M M Seywright; R Lever; N P Lucie

doi:10.1111/j.1365-2133.1990.tb04202.x

Angiotropic B-cell lymphoma (malignant angioendotheliomatosis): failure of systemic chemotherapy

Br J Dermatol. 1990 Dec;123(6):807-10. doi: 10.1111/j.1365-2133.1990.tb04202.x.

Authors

R E Williams¹, M M Seywright, R Lever, N P Lucie

Affiliation

¹ Department of Dermatology, Western Infirmary, Glasgow, U.K.

PMID: 2265097
DOI: 10.1111/j.1365-2133.1990.tb04202.x

Abstract

A 65-year-old female with angiotropic B-cell lymphoma is reported. Despite the absence of systemic involvement on formal staging and the favourable response of the cutaneous lesions to triple systemic chemotherapy with prednisolone, vincristine and cyclophosphamide, postmortem findings showed that death was due to widespread disease dissemination.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Allopurinol / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Chlorambucil / therapeutic use
Cyclophosphamide / administration & dosage
Female
Humans
Lymphoma, B-Cell / drug therapy*
Lymphoma, B-Cell / pathology
Prednisolone / administration & dosage
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology
Vincristine / administration & dosage

Substances

Chlorambucil
Vincristine
Allopurinol
Cyclophosphamide
Prednisolone